Identification and antifungal susceptibility of a large collection of yeast strains isolated in Tunisian hospitals

References

• Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010; 50: 1101–1111.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133–163.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M. Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008–2009. Antimicrob Agents Chemother 2011; 55: 561–566.
   PubMed Web of Science ®Google Scholar
• Cassone M, Serra P, Mondello F, et al. Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. J Clin Microbiol 2003; 41: 5340–5343.
   PubMed Web of Science ®Google Scholar
• Thakur K, Singh G, Agarwal S, Rani L. Meningitis caused by Rhodotorula rubra in an human immunodeficiency virus infected patient. Indian J Med Microbiol 2007; 25: 166–168.
   PubMedGoogle Scholar
• Taj-Aldeen SJ, Doiphode SH, Han XY. Kodamaea (Pichia) ohmeri fungaemia in a premature neonate. J Med Microbiol 2006; 55: 237–239.
   PubMed Web of Science ®Google Scholar
• Adler A, Hidalgo-Grass C, Boekhout T, et al. Pichia farinosa bloodstream infection in a lymphoma patient. J Clin Microbiol 2007; 45: 3456–3458.
   PubMed Web of Science ®Google Scholar
• Shang ST, Yang YS, Peng MY. Nosocomial Trichosporon asahii fungemia in a patient with secondary hemochromatosis: a rare case report. J Microbiol Immunol Infect 2010; 43: 77–80.
   PubMedGoogle Scholar
• Suzuki T, Hori N, Miyake T, Hori Y, Mochizuki K. Keratitis caused by a rare fungus, Malassezia restricta. Jpn J Ophthalmol 2007; 51: 292–294.
   PubMedGoogle Scholar
• Cendejas-Bueno E, Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M. Identification of pathogenic rare yeast species in clinical samples: comparison between phenotypical and molecular methods. J Clin Microbiol 2010; 48: 1895–1899.
   PubMed Web of Science ®Google Scholar
• Paredes K, Sutton DA, Cano J, et al. Molecular identification and antifungal susceptibility testing of clinical isolates of the Candida rugosa species complex and proposal of the new species Candida neorugosa. J Clin Microbiol 2012; 50: 2397–2403.
   Web of Science ®Google Scholar
• Seyfarth F, Wiegand C, Erhard M, et al. Identification of yeast isolated from dermatological patients by MALDI-TOF mass spectrometry. Mycoses 2012; 55: 276–280.
   PubMed Web of Science ®Google Scholar
• Hata DJ, Hall L, Fothergill AW, Larone DH, Wengenack NL. Multicenter evaluation of the new VITEK 2 advanced colorimetric yeast identification card. J Clin Microbiol 2007; 45: 1087–1092.
   Google Scholar
• Verweij PE, Breuker IM, Rijs AJ, Meis JF. Comparative study of seven commercial yeast identification systems. J Clin Pathol 1999; 52: 271–273.
   PubMed Web of Science ®Google Scholar
• Marot-Leblond A, Beucher B, David S, Nail-Billaud S, Robert R. Development and evaluation of a rapid latex agglutination test using a monoclonal antibody to identify Candida dubliniensis colonies. J Clin Microbiol 2006; 44: 138–142.
   PubMed Web of Science ®Google Scholar
• Coignard C, Hurst SF, Benjamin LE, et al. Resolution of discrepant results for Candida species identification by using DNA probes. J Clin Microbiol 2004; 42: 858–861.
   PubMed Web of Science ®Google Scholar
• Cornet M, Sendid B, Fradin C, et al. Molecular identification of closely related Candida species using two ribosomal intergenic spacer fingerprinting methods. J Mol Diagn 2011; 13: 12–22.
   Google Scholar
• Groenewald M, Robert V, Smith MT. The value of the D1/D2 and internal transcribed spacers (ITS) domains for the identification of yeast species belonging to the genus Yamadazyma. Persoonia 2011; 26: 40–46.
   Google Scholar
• Schoch CL, Seifert KA, Huhndorf S, et al. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for fungi. Proc Natl Acad Sci USA 2012; 109: 6241–6246.
   PubMed Web of Science ®Google Scholar
• Carbonnelle E, Mesquita C, Bille E, et al. MALDI-TOF mass spectrometry tools for bacterial identification in clinical microbiology laboratory. Clin Biochem 2011; 44: 104–109.
   PubMed Web of Science ®Google Scholar
• Marklein G, Josten M, Klanke U, et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol 2009; 47: 2912–2917.
   PubMed Web of Science ®Google Scholar
• Pinto A, Halliday C, Zahra M, et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry identification of yeasts is contingent on robust reference spectra. PLoS One 2011; 6: e25712.
   PubMed Web of Science ®Google Scholar
• Bader O, Weig M, Taverne-Ghadwal L, et al. Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Microbiol Infect 2011; 17: 1359–1365.
   PubMed Web of Science ®Google Scholar
• Alanio A, Beretti JL, Dauphin B, et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species. Clin Microbiol Infect 2011; 17: 750–755.
   PubMed Web of Science ®Google Scholar
• De Carolis E, Posteraro B, Lass-Florl C, et al. Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Microbiol Infect 2012; 18: 475–484.
   PubMed Web of Science ®Google Scholar
• Quiles-Melero I, Garcia-Rodriguez J, Gomez-Lopez A, Mingorance J. Evaluation of matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry for identification of Candida parapsilosis, C. orthopsilosis and C. metapsilosis. Eur J Clin Microbiol Infect Dis 2012; 31: 67–71.
   PubMed Web of Science ®Google Scholar
• Eddouzi J, Hofstetter V, Groenewald M, Manai M, Sanglard D. Characterization of a new clinical yeast species, Candida tunisiensis sp. nov., isolated from a strain collection from Tunisian hospitals. J Clin Microbiol 2013; 51: 31–39.
   Google Scholar
• Fluckiger U, Marchetti O, Bille J, et al. Treatment options of invasive fungal infections in adults. Swiss Med Wkly 2006; 136: 447–463.
   PubMed Web of Science ®Google Scholar
• Zonios DI, Bennett JE. Update on azole antifungals. Semin Respir Crit Care Med 2008; 29: 198–210.
   PubMed Web of Science ®Google Scholar
• Sanglard D. Resistance of human fungal pathogens to antifungal drugs. Curr Opin Microbiol 2002; 5: 379–385.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Gibbs DL, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 2007; 45: 1735–1745.
   PubMed Web of Science ®Google Scholar
• Hachem R, Hanna H, Kontoyiannis D, Jiang Y, Raad I. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer 2008; 112: 2493–2499.
   PubMed Web of Science ®Google Scholar
• Diekema D, Arbefeville S, Boyken L, Kroeger J, Pfaller M. The changing epidemiology of healthcare-associated candidemia over three decades. Diagcm Microbiol Inf Dis 2012; 73: 45–48.
   PubMed Web of Science ®Google Scholar
• Lockhart SR, Iqbal N, Cleveland AA, et al. Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol 2012; 50: 3435–3442.
   PubMed Web of Science ®Google Scholar
• Sanglard D, Ischer F, Bille J. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata. Antimicrob Agents Chemother 2001; 45: 1174–1183.
   PubMed Web of Science ®Google Scholar
• Sanglard D, Ischer F, Monod M, Bille J. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 1996; 40: 2300–2305.
   PubMed Web of Science ®Google Scholar
• Hazen KC, Baron EJ, Colombo AL, et al. Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion. J Clin Microbiol 2003; 41: 5623–5632.
   PubMedGoogle Scholar
• Clinical and Laboratory Standards Institute. Method for Antifungal Disk Diffusion SusceptibilityTesting of Yeasts, approved guideline M44-A. Wayne, PA: Clinical and Laboratory Standards Institute; 2004.
   Google Scholar
• Pfaller MA, Diekema DJ, Rex JH, et al. Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol 2006; 44: 819–826.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Andes D, Arendrup MC, et al. Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagnostic microbiology and infectious disease 2011; 70: 330–343.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Andes D, Diekema DJ, Espinel-Ingroff A, Sheehan D. Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resist Updat 2010; 13: 180–195.
   PubMed Web of Science ®Google Scholar
• Eraso E, Moragues MD, Villar-Vidal M, et al. Evaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species. J Clin Microbiol 2006; 44: 3340–3345.
   PubMed Web of Science ®Google Scholar
• Horvath LL, Hospenthal DR, Murray CK, Dooley DP. Direct isolation of Candida spp. from blood cultures on the chromogenic medium CHROMagar Candida. J Clin Microbiol 2003; 41: 2629–2632.
   PubMed Web of Science ®Google Scholar
• Sahand IH, Maza JL, Eraso E, et al. Evaluation of CHROM-Pal medium for the isolation and direct identification of Candida dubliniensis in primary cultures from the oral cavity. J Med Microbiol 2009; 58: 1437–1442.
   PubMed Web of Science ®Google Scholar
• Tintelnot K, Haase G, Seibold M, et al. Evaluation of phenotypic markers for selection and identification of Candida dubliniensis. J Clin Microbiol 2000; 38: 1599–1608.
   PubMed Web of Science ®Google Scholar
• Hospenthal DR, Beckius ML, Floyd KL, Horvath LL, Murray CK. Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida. Ann Clin Microbiol Antimicrob 2006; 5: 1.
   PubMedGoogle Scholar
• Cooke VM, Miles RJ, Price RG, et al. New chromogenic agar medium for the identification of Candida spp. Appl Environ Microbiol 2002; 68: 3622–3627.
   PubMed Web of Science ®Google Scholar
• Jensen RH, Arendrup MC. Candida palmioleophila: characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species. J Clin Microbiol 2011; 49: 549–556.
   PubMed Web of Science ®Google Scholar
• Stevenson LG, Drake SK, Shea YR, Zelazny AM, Murray PR. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically important yeast species. J Clin Microbiol 2010; 48: 3482–3486.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Gibbs DL, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol 2010; 48: 1366–1377.
   PubMed Web of Science ®Google Scholar
• Mandras N, Tullio V, Allizond V, et al. In vitro activities of fluconazole and voriconazole against clinical isolates of Candida spp. determined by disk diffusion testing in Turin, Italy. Antimicrob Agents Chemother 2009; 53: 1657–1659.
   PubMed Web of Science ®Google Scholar
• Wang H, Xiao M, Chen SC, et al. In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study. J Clin Microbiol 2012; 50: 3952–3959.
   PubMed Web of Science ®Google Scholar
• Schubert S, Popp C, Rogers PD, Morschhauser J. Functional dissection of a Candida albicans zinc cluster transcription factor, the multidrug resistance regulator Mrr1. Eukaryot Cell 2011; 10: 1110–1121.
   Google Scholar
• Morschhauser J, Barker KS, Liu TT, et al. The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans. PLoS Pathog 2007; 3: e164.
   PubMed Web of Science ®Google Scholar
• Ferrari S, Ischer F, Calabrese D, et al. Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS Pathog 2009; 5: e1000268.
   Google Scholar
• Brun S, Aubry C, Lima O, et al. Relationships between respiration and susceptibility to azole antifungals in Candida glabrata. Antimicrob Agents Chemother 2003; 47: 847–853.
   Google Scholar
• Bouchara JP, Zouhair R, Le Boudouil S, et al. In vivo selection of an azole-resistant petite mutant of Candida glabrata. J Med Microbiol 2000; 49: 977–984.
   PubMed Web of Science ®Google Scholar
• Ferrari S, Sanguinetti M, Torelli R, Posteraro B, Sanglard D. Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrata. PloS one 2011; 6: e17589.
   PubMed Web of Science ®Google Scholar
• Barchiesi F, Calabrese D, Sanglard D, et al. Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Chemother 2000; 44: 1578–1584.
   PubMed Web of Science ®Google Scholar
• Jensen RH, Arendrup MC. Candida palmioleophila: characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species. J Clin Microbiol 2011; 49: 549–556.
   PubMed Web of Science ®Google Scholar
• Mota AJ, Back-Brito GN, Nobrega FG. Molecular identification of Pichia guilliermondii, Debaryomyces hansenii and Candida palmioleophila. Genet Mol Biol 2012; 35: 122–125.
   Google Scholar
• Shang ST, Lin JC, Ho SJ, et al. The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review. J Microbiol Immunol Infect 2010; 43: 200–206.
   Google Scholar
• Al-Sweih N, Khan ZU, Ahmad S, et al. Kodamaea ohmeri as an emerging pathogen: a case report and review of the literature. Med Mycol 2011; 49: 766–770.
   PubMed Web of Science ®Google Scholar
• Sundaram PS, Bijulal S, Tharakan JA, Antony M. Kodamaea ohmeri tricuspid valve endocarditis with right ventricular inflow obstruction in a neonate with structurally normal heart. Ann Pediatr Cardiol 2011; 4: 77–80.
   PubMedGoogle Scholar
• Santino I, Bono S, Borruso L, et al. Kodamaea ohmeri isolate from two immunocompromised patients: first report in Italy. Mycoses 2012.
   Google Scholar
• Kurtzman CP, Robnett CJ. Phylogenetic relationships among yeasts of the ‘Saccharomyces complex’ determined from multigene sequence analyses. FEMS Yeast Res 2003; 3: 417–432.
   PubMed Web of Science ®Google Scholar